Crawford Investment Counsel’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $118M | Sell |
1,361,046
-334
| -0% | -$32K | 2.01% | 11 |
|
|
2025
Q4 | $131M | Buy |
1,361,380
+8,318
| +0.6% | +$808K | 2.18% | 7 |
|
|
2025
Q3 | $129M | Buy |
1,353,062
+9,651
| +0.7% | +$887K | 2.14% | 6 |
|
|
2025
Q2 | $117M | Buy |
1,343,411
+6,423
| +0.5% | +$545K | 2.05% | 8 |
|
|
2025
Q1 | $120M | Buy |
1,336,988
+113,499
| +9% | +$10.2M | 2.13% | 8 |
|
|
2024
Q4 | $97.7M | Buy |
1,223,489
+13,539
| +1% | +$1.17M | 1.76% | 16 |
|
|
2024
Q3 | $109M | Buy |
1,209,950
+16,384
| +1% | +$1.38M | 1.86% | 12 |
|
|
2024
Q2 | $93.9M | Buy |
1,193,566
+27,758
| +2% | +$2.28M | 1.79% | 15 |
|
|
2024
Q1 | $102M | Buy |
1,165,808
+25,955
| +2% | +$2.22M | 1.89% | 13 |
|
|
2023
Q4 | $93.9M | Buy |
1,139,853
+2,157
| +0.2% | +$164K | 1.88% | 12 |
|
|
2023
Q3 | $89.1M | Sell |
1,137,696
-2,014
| -0.2% | -$169K | 1.93% | 13 |
|
|
2023
Q2 | $100M | Buy |
1,139,710
+29,874
| +3% | +$2.57M | 2.04% | 12 |
|
|
2023
Q1 | $89.5M | Buy |
1,109,836
+121,003
| +12% | +$9.86M | 1.91% | 14 |
|
|
2022
Q4 | $76.9M | Buy |
988,833
+38,471
| +4% | +$3.12M | 1.65% | 20 |
|
|
2022
Q3 | $76.7M | Buy |
950,362
+123,186
| +15% | +$11.1M | 1.81% | 14 |
|
|
2022
Q2 | $74.2M | Sell |
827,176
-27,330
| -3% | -$2.77M | 1.64% | 18 |
|
|
2022
Q1 | $94.8M | Buy |
854,506
+49,473
| +6% | +$5.23M | 1.84% | 15 |
|
|
2021
Q4 | $83.3M | Buy |
805,033
+50,206
| +7% | +$5.81M | 1.58% | 21 |
|
|
2021
Q3 | $94.6M | Sell |
754,827
-3,962
| -0.5% | -$513K | 1.93% | 14 |
|
|
2021
Q2 | $94.2M | Buy |
758,789
+46,647
| +7% | +$5.86M | 1.9% | 16 |
|
|
2021
Q1 | $84.1M | Buy |
712,142
+8,924
| +1% | +$1.05M | 1.9% | 13 |
|
|
2020
Q4 | $82.4M | Sell |
703,218
-16,609
| -2% | -$1.83M | 2.03% | 13 |
|
|
2020
Q3 | $74.8M | Buy |
719,827
+8,328
| +1% | +$836K | 2.04% | 15 |
|
|
2020
Q2 | $65.2M | Buy |
711,499
+2,952
| +0.4% | +$283K | 1.87% | 19 |
|
|
2020
Q1 | $63.9M | Sell |
708,547
-2,984
| -0.4% | -$317K | 2.15% | 13 |
|
|
2019
Q4 | $80.7M | Sell |
711,531
-5,818
| -0.8% | -$638K | 2.09% | 14 |
|
|
2019
Q3 | $77.9M | Sell |
717,349
-17,896
| -2% | -$1.87M | 2.16% | 10 |
|
|
2019
Q2 | $71.6M | Buy |
735,245
+8,808
| +1% | +$804K | 2.02% | 16 |
|
|
2019
Q1 | $66.2M | Buy |
726,437
+10,059
| +1% | +$900K | 1.97% | 18 |
|
|
2018
Q4 | $65.2M | Sell |
716,378
-30,005
| -4% | -$2.8M | 2.21% | 13 |
|
|
2018
Q3 | $73.4M | Buy |
746,383
+4,977
| +0.7% | +$460K | 2.24% | 12 |
|
|
2018
Q2 | $63.5M | Sell |
741,406
-2,381
| -0.3% | -$199K | 2.02% | 16 |
|
|
2018
Q1 | $59.7M | Buy |
743,787
+24,386
| +3% | +$2.01M | 1.88% | 18 |
|
|
2017
Q4 | $58.1M | Buy |
719,401
+31,218
| +5% | +$2.5M | 1.8% | 22 |
|
|
2017
Q3 | $53.5M | Buy |
688,183
+35,904
| +6% | +$2.98M | 1.74% | 24 |
|
|
2017
Q2 | $57.9M | Buy |
652,279
+5,600
| +0.9% | +$472K | 1.99% | 15 |
|
|
2017
Q1 | $52.1M | Buy |
646,679
+23,449
| +4% | +$1.83M | 1.85% | 22 |
|
|
2016
Q4 | $44.4M | Buy |
623,230
+27,095
| +5% | +$2.13M | 1.61% | 28 |
|
|
2016
Q3 | $51.5M | Sell |
596,135
-2,665
| -0.4% | -$232K | 1.89% | 21 |
|
|
2016
Q2 | $52M | Buy |
598,800
+29,848
| +5% | +$2.41M | 2.07% | 20 |
|
|
2016
Q1 | $42.7M | Buy |
568,952
+102,863
| +22% | +$7.75M | 1.79% | 24 |
|
|
2015
Q4 | $35.9M | Buy |
466,089
+462,310
| +12,234% | +$34.8M | 1.58% | 29 |
|
|
2015
Q3 | $253K | Buy |
+3,779
| New | +$278K | 0.01% | 229 |
|
|
2015
Q2 | – | Sell |
-9,387
| Closed | -$732K | – | 250 |
|
|
2015
Q1 | $732K | Buy |
9,387
+180
| +2% | +$13.6K | 0.03% | 167 |
|
|
2014
Q4 | $665K | Sell |
9,207
-7
| -0.1% | -$486 | 0.02% | 169 |
|
|
2014
Q3 | $571K | Buy |
9,214
+322
| +4% | +$20.5K | 0.02% | 180 |
|
|
2014
Q2 | $567K | Hold |
8,892
| – | – | 0.02% | 177 |
|
|
2014
Q1 | $547K | Hold |
8,892
| – | – | 0.02% | 169 |
|
|
2013
Q4 | $510K | Buy |
+8,892
| New | +$504K | 0.02% | 175 |
|
Other funds holding MDT
VCM
VPM
Crawford Investment Counsel's MDT Position: Q1 2026 in Review
Crawford Investment Counsel reduced its Medtronic (MDT) stake by 0.02% in Q1 2026, selling an estimated $32K and leaving 1,361,046 shares worth $118M. The position accounts for 2.01% of the portfolio, ranked #11.
Crawford Investment Counsel first reported a position in MDT in Q4 2013 and has held it in 49 quarters since. The position peaked at $131M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Crawford Investment Counsel held 1,361,046 shares of Medtronic worth $118M as of Q1 2026.
- Crawford Investment Counsel sold 334 Medtronic shares in Q1 2026, an estimated $32K.
- Medtronic made up 2.01% of Crawford Investment Counsel's portfolio in Q1 2026, its #11 holding.
- Crawford Investment Counsel first reported a position in Medtronic in Q4 2013 and has held it in 49 quarters since.
- Crawford Investment Counsel's Medtronic position peaked at $131M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.